GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 111 filers reported holding GENOMIC HEALTH INC in Q1 2015. The put-call ratio across all filers is 4.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $626,973,000 | +16.4% | 9,244,665 | -0.2% | 4.26% | +16.5% |
| Q2 2019 | $538,708,000 | -24.6% | 9,260,922 | -9.2% | 3.66% | -19.9% |
| Q1 2019 | $714,436,000 | -5.6% | 10,198,943 | -13.2% | 4.57% | -26.2% |
| Q4 2018 | $756,432,000 | -21.9% | 11,744,010 | -14.8% | 6.19% | -2.9% |
| Q3 2018 | $968,402,000 | +39.3% | 13,790,970 | +0.0% | 6.38% | +22.2% |
| Q2 2018 | $695,045,000 | +61.1% | 13,790,574 | +0.0% | 5.22% | +42.8% |
| Q1 2018 | $431,487,000 | -8.5% | 13,789,936 | +0.1% | 3.66% | -10.5% |
| Q4 2017 | $471,314,000 | +6.6% | 13,781,102 | +0.0% | 4.08% | +13.9% |
| Q3 2017 | $442,215,000 | -1.4% | 13,780,480 | +0.0% | 3.59% | -8.5% |
| Q2 2017 | $448,535,000 | +3.4% | 13,779,866 | +0.1% | 3.92% | +10.5% |
| Q1 2017 | $433,648,000 | +7.2% | 13,770,982 | +0.0% | 3.55% | -10.6% |
| Q4 2016 | $404,709,000 | +1.6% | 13,770,302 | 0.0% | 3.97% | +9.8% |
| Q3 2016 | $398,237,000 | +12.5% | 13,770,302 | +0.7% | 3.61% | -2.6% |
| Q2 2016 | $353,955,000 | +4.6% | 13,668,866 | +0.1% | 3.71% | +4.0% |
| Q1 2016 | $338,354,000 | -29.6% | 13,659,832 | +0.0% | 3.57% | -10.4% |
| Q4 2015 | $480,806,000 | +66.4% | 13,659,264 | +0.0% | 3.98% | +49.2% |
| Q3 2015 | $289,011,000 | -23.9% | 13,658,328 | +0.0% | 2.67% | -19.8% |
| Q2 2015 | $379,545,000 | -9.0% | 13,657,598 | +0.0% | 3.33% | -4.1% |
| Q1 2015 | $417,220,000 | -4.4% | 13,656,942 | +0.0% | 3.47% | -22.1% |
| Q4 2014 | $436,592,000 | +12.9% | 13,656,318 | +0.0% | 4.46% | -8.5% |
| Q3 2014 | $386,590,000 | +3.3% | 13,655,618 | +0.0% | 4.87% | +6.2% |
| Q2 2014 | $374,144,000 | +4.0% | 13,654,902 | +0.0% | 4.58% | +0.3% |
| Q1 2014 | $359,650,000 | -10.0% | 13,654,150 | +0.0% | 4.57% | -18.8% |
| Q4 2013 | $399,560,000 | -4.3% | 13,650,835 | 0.0% | 5.63% | -5.1% |
| Q3 2013 | $417,442,000 | -3.6% | 13,650,835 | 0.0% | 5.93% | -30.7% |
| Q2 2013 | $432,868,000 | – | 13,650,835 | – | 8.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,150,000 | $68,736,000 | 4.57% |
| Baker Brothers Advisors | 13,656,318 | $436,592,000 | 4.46% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $47,955,000 | 3.22% |
| Motley Fool Wealth Management, LLC | 72,732 | $2,325,000 | 1.36% |
| Tributary Capital Management, LLC | 150,896 | $4,824,000 | 0.82% |
| Champlain Investment Partners, LLC | 1,217,175 | $38,913,000 | 0.62% |
| Motley Fool Asset Management LLC | 71,935 | $2,300,000 | 0.43% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 440,410 | $14,080,000 | 0.39% |
| CATAPULT CAPITAL MANAGEMENT LLC | 35,000 | $1,119,000 | 0.28% |
| Spark Investment Management LLC | 51,100 | $1,633,000 | 0.27% |